Browsing Vanderbilt Ingram Cancer Center by Title
Now showing items 1-7 of 7
-
(Journal of Clinical Oncology, 2019-04-20)PURPOSE CheckMate 568 is an open-label phase II trial that evaluated the efficacy and safety of nivolumab plus low-dose ipilimumab as first-line treatment of advanced/metastatic non-small-cell lung cancer (NSCLC). We ...
-
(BMC Medical Genomics, 2019-09-18)Background Although APOBEC-mutational signature is found in tumor tissues of multiple cancers, how a common germline APOBEC3A/B deletion affects the mutational signature remains unclear. Methods Using data from 10 cancer ...
-
(British Journal of Cancer, 2019-08-27)
-
(Blood Cancer Journal, 2019-03-29)This phase I dose-escalation/expansion study evaluated isatuximab (anti-CD38 monoclonal antibody) monotherapy in patients with relapsed/refractory multiple myeloma (RRMM). Patients progressing on or after standard therapy ...
-
(Annals of Surgical Oncology, 2019-10)Background Breast cancer-related lymphedema (BCRL) represents a major source of morbidity among breast cancer survivors. Increasing data support early detection of subclinical BCRL followed by early intervention. A randomized ...
-
(2019-12-11)Background: In medical oncology settings, early specialist palliative care interventions have demonstrated improvements in patient quality of life and survival compared with usual oncologic care. However, the effect of ...
-
(Clinical Lymphoma Myeloma & Leukemia, 2019-09)Approximately half of the patients with polycythemia vera experience substantial symptom burdens. We analyzed data from the ongoing Prospective Observational Study of Patients with Polycythemia Vera in US Clinical Practices ...